Search

FRIDAY, Aug. 28, 2020 (HealthDay News) — The proportion of deaths from heart disease attributed to heart failure and hypertensive heart disease is increasing, according to a study published online Aug. 13 in The BMJ. Nilay S. Shah, M.D., M.P.H., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues present trends in...

THURSDAY, Oct. 15, 2020 (HealthDay News) — Polypharmacy, defined as taking 10 or more medications, is common at admission and hospital discharge among older adults with heart failure, according to a study published online Oct. 13 in Circulation: Heart Failure. Ozan Unlu, M.D., from Weill Cornell Medicine in New York City, and colleagues studied 558...

Heart failure, among other cardiovascular problems, is a typical manifestation of transthyretin amyloidosis cardiomyopathy (ATTR-CM). The prevalence of ATTR-CM as a phenotype of heart failure is often underestimated. Heart failure with preserved ejection fraction (HFpEF) affects more than half of patients with heart failure. The phenotypes of heart failure can vary, and treatment modalities are...

WEDNESDAY, Nov. 25, 2020 (HealthDay News) — Sotagliflozin is beneficial for the treatment of type 2 diabetes in patients with recent worsening heart failure as well as in patients with chronic kidney disease, according to two studies published online Nov. 16 in the New England Journal of Medicine to coincide with the American Heart Association...

A new bombshell research paper conducted by a team of fellows in CIFAR’s Humans and the Microbiome is reporting that long known non-communicable diseases including heart disease, cancer and lung disease possibly can, in fact, be passed along to others through airborne contact.  “If our hypothesis is proven correct, it will rewrite the entire book...

Mortality risk elevated in the first year after transplant for 18- to 30-year-olds; risk also up for those aged 31 to 40 years, 41 to 60 years Young Black heart recipients have an increased risk for mortality in the first year after transplant, according to a study published online Feb. 2 in Circulation: Heart Failure. Hasina...

Empagliflozin is an SGLT-2i with positive treatment outcomes in patients with T2DM and HF, though it was not originally developed for the combination of these conditions. Future long-term and well-designed clinical trials are needed to support these findings. Type 2 diabetes mellitus (T2DM) and heart failure (HF) are the two of the most common medical...

This story was written by the American Heart Association. High blood pressure of any kind in young adults increases the risk of heart attacks, strokes and other cardiovascular events, according to new findings that shed light on an issue experts say has been understudied. Blood pressure readings have two measurements. Systolic is the top number...

Patients who suffer from acute heart failure may be nearly twice as likely to die if they get COVID-19, a new study finds. “Our results support prioritizing heart failure patients for COVID-19 vaccination once it is available,” said researcher Dr. Amardeep Dastidar, a consultant interventional cardiologist at North Bristol NHS Trust and Bristol Heart Institute...

Cardiac amyloidosis, an underdiagnosed cause of heart failure, may present with persistent symptoms even under optimal medical therapy. Early diagnosis and novel treatments may offer hope for better outcomes. Cardiac amyloidosis is a severe form of restrictive cardiomyopathy that can elude diagnosis. Persistent heart failure symptoms may be a red flag for amyloidosis in the...